Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Nicole Lupo

Surgery Oakhurst, NJ Medical Doctor

NPI 1639699713 CMS profile 3000253

255 Monmouth Rd, Oakhurst, NJ 07755

Open in the dashboard

General payments

$7,370

58 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nicole Lupo of Oakhurst, NJ is reported in the CMS Open Payments database as having received $7,370 across 58 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,386 26
2024 General $550 6
2023 General $253 3
2022 General $852 11
2021 General $329 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicole Lupo
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Nicole Lupo were reported at $5,386. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Nicole Lupo Surgery median Middle half National median
2019 $0 $253 $82–$1,521 $163
2020 $0 $131 $40–$706 $114
2021 $329 $168 $50–$904 $132
2022 $852 $224 $76–$1,218 $149
2023 $253 $253 $82–$1,255 $160
2024 $550 $279 $90–$1,381 $164
2025 $5,386 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Integra LifeSciences Corporation $5,831 25 payments
  2. Dilon Technologies, Inc. $479 3 payments
  3. Davol Inc. $273 4 payments
  4. Urgo Medical North America, LLC $143 1 payment
  5. Baudax Bio Inc. $125 1 payment
  6. Kerecis Limited $78 4 payments
  7. Olympus America Inc. $61 3 payments
  8. CONMED Corporation $44 1 payment
  9. Innocoll Incorporated $42 2 payments
  10. Solventum Corporation $38 2 payments
  11. Other $257 12 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Long term medical supply or device loan $4,702 11 payments
  2. Food and Beverage $2,668 47 payments
Products named General payments · program years 2021–2025
  1. MICROMATRIX $3,846 7 payments
  2. INTEGRA DERMAL REGENERATION TEMPLATE $1,130 14 payments
  3. Integra Recon-Skin And Wound $1,086 12 payments
  4. Integra Recon-Skin And Wound $1,086 12 payments
  5. Integra Recon-Skin And Wound $1,086 12 payments
  6. PRIMATRIX $966 13 payments
  7. Cytal $856 4 payments
  8. HEMOBLAST BELLOWS $479 3 payments
  9. ARISTA $186 3 payments
  10. OMNIGRAFT $164 1 payment
  11. Other $1,641 53 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

73

Median for Physician Assistant: 241

Drug cost

$586

Median for Physician Assistant: $4,110

Branded share of claims

39.7%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocortisone Generic 31 $261
Procto-Med Hc Hydrocortisone Brand 15 $190
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 14 $84
Oxycodone Hcl Generic 13 $50

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$8,272

Medicare's payments for the services billed

Medicare patients

141

Average age 75

Services billed

162

75 women, 66 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Ischemic heart disease 47%
Diabetes 35%
Atrial fibrillation 35%
Cancer 33%
Depression 32%
Chronic kidney disease 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

58 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record